Silence Therapeutics Plc (SLN)
13.30
-0.25
(-1.85%)
USD |
NASDAQ |
Sep 10, 16:00
13.30
0.00 (0.00%)
After-Hours: 18:56
Silence Therapeutics Market Cap : 628.38M for Sept. 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 09, 2026 | 640.19M |
| September 08, 2026 | 646.80M |
| September 04, 2026 | 689.32M |
| September 03, 2026 | 698.77M |
| September 02, 2026 | 698.77M |
| September 01, 2026 | 696.41M |
| August 31, 2026 | 639.24M |
| August 28, 2026 | 634.05M |
| August 27, 2026 | 635.46M |
| August 26, 2026 | 639.24M |
| August 25, 2026 | 645.86M |
| August 24, 2026 | 627.90M |
| August 21, 2026 | 626.96M |
| August 20, 2026 | 622.24M |
| August 19, 2026 | 643.02M |
| August 18, 2026 | 666.17M |
| August 17, 2026 | 677.99M |
| August 14, 2026 | 648.22M |
| August 13, 2026 | 660.03M |
| August 12, 2026 | 641.61M |
| August 11, 2026 | 695.47M |
| August 10, 2026 | 729.01M |
| August 07, 2026 | 564.59M |
| August 06, 2026 | 553.73M |
| August 05, 2026 | 530.92M |
| Date | Value |
|---|---|
| August 04, 2026 | 527.61M |
| August 03, 2026 | 504.47M |
| July 31, 2026 | 495.49M |
| July 30, 2026 | 548.87M |
| July 29, 2026 | 545.56M |
| July 28, 2026 | 545.56M |
| July 27, 2026 | 570.12M |
| July 24, 2026 | 520.53M |
| July 23, 2026 | 540.84M |
| July 22, 2026 | 558.79M |
| July 21, 2026 | 512.50M |
| July 20, 2026 | 495.49M |
| July 17, 2026 | 495.96M |
| July 16, 2026 | 515.80M |
| July 15, 2026 | 493.60M |
| July 14, 2026 | 460.54M |
| July 13, 2026 | 438.81M |
| July 10, 2026 | 429.36M |
| July 09, 2026 | 465.73M |
| July 08, 2026 | 469.98M |
| July 07, 2026 | 479.43M |
| July 06, 2026 | 499.74M |
| July 02, 2026 | 490.77M |
| July 01, 2026 | 495.96M |
| June 30, 2026 | 518.64M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Biodexa Pharmaceuticals Plc | 0.3044M |
| Mereo BioPharma Group Plc | 38.71M |
| NuCana Plc | 5.861M |
| Autolus Therapeutics Plc | 520.35M |
| Compass Pathways Plc | 1.931B |
Market Cap Related Metrics
| PS Ratio | 1024.33 |
| Price to Book Value | 16.33 |
| Price | 13.30 |
| Earnings Yield | -9.52% |